Optimizing Frontline Therapy for CML: Balancing Efficacy, Safety, and Long-Term Tolerability
October 8, 2026
5:30 pm
Upcoming
GLP-1s and Cardiovascular Risk in Patients with Type 2 Diabetes: Translating Outcomes Data into Clinical Practice
October 8, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
October 14, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
October 15, 2026
5:30 pm
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
October 20, 2026
5:30 pm
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
October 21, 2026
5:30 pm
Upcoming
Elevating the Pharmacist’s Role in Optimizing Adjuvant Care for High-Risk cSCC
October 22, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
October 27, 2026
5:30 pm
Upcoming
Optimizing Frontline Therapy for CML: Balancing Efficacy, Safety, and Long-Term Tolerability
October 27, 2026
5:30 pm
Upcoming
Mind the Gap: Strengthening Access Pathways in Obesity Care
October 29, 2026
5:30 pm
Upcoming
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact
November 3, 2026
5:30 pm
Upcoming
Optimizing Weight Loss: Differentiating GLP-1 Therapies in Personalized Obesity Management
November 4, 2026
6:00 pm
Upcoming